Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Mun la chn c sn phm 100% chnh hng, m bo cht lng tt th nn u tin t hng ti nhng shop ng tin cy, nhn c nh gi tt t ngi mua trc
Saxenda is approved for: Adults Adults with obesity (BMI of 30 kg/m or greater) Adults who are overweight (BMI of 27 kg/m or greater) and have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol Children aged 12 and older Adolescents with obesity who weigh more than 60 kg (132 pounds) Limitations of use Saxenda should not be used together with other medicines that contain liraglutide, such as Victoza, or with any other GLP-1 receptor agonist, such as Ozempic, Wegovy, or Trulicity The safety and effectiveness of Saxenda in children aged 12 to 17 years who have type 2 diabetes have not been established
FIND NOW Attention: Restrictions on use of SMSNA content in third party applications, including artificial intelligence technologies, such as large language models and generative AI
Fajar JK, Ilmawan M, Mamada SS, et al
Michael Costello, CEO of GNC, underscores the alignment with their goal of finding scientifically-backed products to enhance health, highlighting Supergut as a top choice for improving digestive health naturally
While not all inclusive, a few of the potential future indications that are being explored for GLP1 receptor agonists are listed below
